Susquehanna International Group
DMAQR

Susquehanna International Group’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Susquehanna International Group’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,749
Closed -$1K – 14110
2022
Q3 		$1K Sell
16,749
-26,801
-62% -$2.96K ﹤0.01% 13009
2022
Q2 		$5K Buy
+43,550
New +$7.09K ﹤0.01% 12609
2022
Q1 		– Sell
-15,124
Closed -$5K – 14258
2021
Q4 		$5K Buy
+15,124
New +$4.78K ﹤0.01% 12991

Other funds holding DMAQR

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Susquehanna International Group's DMAQR Position: Q4 2022 in Review

Susquehanna International Group sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q4 2022, closing a stake of 16,749 shares — an estimated $1K sold.

Susquehanna International Group first reported a position in DMAQR in Q4 2021 and held it in 3 quarters. The position peaked at $5K in Q2 2022. 29 funds tracked by Wall St. Rank hold DMAQR as of Q4 2022.

  • Susquehanna International Group reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 16,749 Deep Medicine Acquisition Corp. Rights shares in Q4 2022, an estimated $1K.
  • Susquehanna International Group first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 3 quarters.
  • Susquehanna International Group's Deep Medicine Acquisition Corp. Rights position peaked at $5K in Q2 2022.
  • 29 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.